dr. yee on phase ii adapt trial results for her2 /hr breast cancer
Published 8 years ago • 227 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
0:47
dr. yee on neoadjuvant pertuzumab in her2-positive breast cancer
-
1:22
dr. slamon the phase iii results of monaleesa-3 trial in hr /her2- breast cancer
-
0:52
dr. yee on neoadjuvant therapy for triple-negative breast cancer
-
4:36
phase iii clinical trials in her2-positive breast cancer
-
0:59
dr waks on unmet needs in patients with her2 breast cancer
-
2:27
dr. yardley on the aphinity trial for her2-positive breast cancer
-
0:51
dr. kass on testing for her2-positive breast cancer
-
2:30
dr. pegram on neoadjuvant treatments for her2-postive breast cancer
-
0:59
dr. burstein on the results of the apt trial for her2 breast cancer
-
20:25
her2 early-stage breast cancer: peri-operative therapy
-
0:52
dr. graff on genomic risk prediction in hr /her2- breast cancer
-
1:53
dr. pegram on pertuzumab combination for her2-positive breast cancer
-
1:37
dr. yardley on hermione-2 trial for her2 breast cancer
-
1:38
dr. debu tripathy discusses the updated emilia trial results for t-dm1
-
1:19
dr. slamon on os results of the monaleesa-3 trial in hr /her2- breast cancer
-
1:30
dr. von minckwitz on phase iii results of the aphinity trial for breast cancer
-
1:57
dr. dietrich on adverse event management for neratinib in breast cancer
-
1:44
dr. tolaney on the atempt trial for her2 breast cancer
-
0:49
dr. o’regan on prognostic value of pcr in her2 breast cancer